Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Period end update

13 Oct 2011 07:00

RNS Number : 0892Q
e2v technologies PLC
13 October 2011
 



 

13 October 2011

 

e2v technologies plc

 

Period end update

 

e2v technologies plc, the specialist provider of technology solutions for high performance systems, is today providing this period end update for the six months ended 30 September 2011.

 

Current Year trading and outlook

 

Group trading for the first half is expected to be in line with management's expectations and ahead of the comparable period in the previous year. Underlying revenue grew by over 16%, with reported revenue growth of 9%. The difference largely reflects one off revenues of £6m.

 

The broader macro economic environment remains of concern and there are some signs of softening demand.

 

We continue to make good progress in executing our strategic plan and our outlook for the full year remains unchanged.

 

RF Power Solutions

 

The RF Power Solutions Division has three key applications: radiotherapy, electronic countermeasures and industrial processing.

 

- Strong growth over the comparable period in radiotherapy reflects steady OEM demand.

- As anticipated, European demand for electronic countermeasures (ECM) continues to be lower. We have secured an order for microwave power modules from a European OEM and are also making good progress with two US ECM programmes.

- In industrial processing systems, agreement has been reached for the first commercial field trial installation of our ProWave™ vermiculite processing system, which is due to be installed shortly. We have made good progress on our development programmes and have recently received a further order for an RF generator to support research into a new potential application in the mining sector.

- The remaining product lines in the division, which serve predominantly commercial and industrial markets, continue to perform well relative to the prior year and steadily on a sequential basis.

 

 

 

High Performance Imaging Solutions

 

The three key applications of this division are: machine vision, space imaging and scientific imaging.

 

- The machine vision sector delivered comparable underlying performance with the prior year, although this has shown some recent softness.

- Space imaging has delivered significant growth over the comparable period, reflecting the achievement of milestones on established programmes and progress on new projects. We have received an order for a focal array subsystem for a Korean land based telescope and have been selected to provide the camera for a ground based space science application in Brazil.

- Scientific imaging is also showing good growth arising from stronger end user demand.

- The remaining product lines in the division continue to show good underlying growth.

 

Hi-rel Semiconductor Solutions

 

This division addresses two main sectors: Semiconductor Lifecycle Management (SLiM™) and aerospace and defence semiconductors.

 

- The SLiM™ programme continues to benefit from the successful delivery within its existing programmes and a further four new defence programmes in Europe and the US have been added in the period, as well as the extension of the Raytheon F15 contract to cover further product lines. We also secured our first customer contract to provide extended product availability in collaboration with Maxim Semiconductors Inc.

- For the remaining product lines in the division we have seen improved demand for test and assembly services in Europe and the US compared to the prior year.

 

Order Book

 

Our total order book as at 30 September 2011 was £146m (30 September 2010 £167m), whilst our order book for delivery in the coming 12 months as at 30 September 2011 was £120m (30 September 2010 £147m). The reduction in the order book for delivery in the coming 12 months reflects a £7m reduction in the level of 'one-off' orders and the cycle of multiyear radiotherapy orders of £9m. We are also seeing a change in mix, as European defence activity (reduced by £2m) has been replaced with more commercial and industrial business with shorter order cycles.

 

 

 

Net Borrowings

 

Net borrowings at 30 September 2011 increased from 30 June 2011 by £4m to £32m, with operational cash performance in line with our expectations.

 

The group's new £80m revolving banking facility became effective 27 July 2011 and expires on 27 July 2015. As at 30 September 2011 the group had available £41m of undrawn committed borrowings from the facility.

 

The group remains in a sound financial position.

 

 

 

Keith Attwood, Chief Executive, said:

 

"The group has performed strongly in the first half. The changing order book profile reflects the anticipated change in the mix of our businesses.

 

The broader macro economic environment remains of concern and there are some signs of softening demand.

 

We continue to make good progress in executing our strategic plan. We are securing early orders for our industrial processing systems business and repositioning ourselves in the value chain for key applications such as space imaging and electronic counter measures.

 

Our outlook for the full year remains unchanged."

 

 

 

Further enquiries:

 

e2v technologies plc

Tel: +44 (0)1245 493 493

Keith Attwood, Chief Executive

Charles Hindson, Group Finance Director

Website: www.e2v.com

Pelham Bell Pottinger

Tel: +44 (0)20 7861 3232

Archie Berens

Clare Gilbey

 

 

Notes to editors

 

 

1. Net borrowings exclude capitalised borrowing costs.

 

2. All financial information included in this release is sourced from management accounts.

 

3. Statements made in this announcement that look forward in time or that express management's beliefs, expectations or estimates regarding future occurrences are "forward-looking statements" within the meaning of the United States federal securities laws. These forward-looking statements reflect the Group's current expectations concerning future events and actual results may differ materially from current expectations or historical results.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMMMMGNZGGMZM
Date   Source Headline
3rd Jan 20144:37 pmRNSHolding(s) in Company
5th Dec 201311:42 amRNSAdditional Listing
27th Nov 201311:35 amRNSGeneral Meeting
19th Nov 20134:25 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
14th Nov 20133:27 pmRNSNotification of Major Interest in Shares
14th Nov 201312:49 pmRNSNotice of General Meeting
6th Nov 20134:57 pmRNSTransaction in Own Shares
4th Nov 201311:44 amRNSDirector/PDMR Shareholding
4th Nov 20137:00 amRNSHalf-year results for six months to 30 Sept 2013
18th Oct 20137:00 amRNSAppointment of Chief Executive
15th Oct 20137:00 amRNSPeriod end update
14th Oct 20134:15 pmRNSHolding(s) in Company
1st Oct 20134:51 pmRNSTransaction in Own Shares
27th Sep 20134:18 pmRNSPurchase of Own Shares
23rd Sep 20134:00 pmRNSShare buy-back programme
19th Aug 20132:15 pmRNSTotal Voting Rights
13th Aug 20134:15 pmRNSHolding(s) in Company
13th Aug 20131:30 pmRNSDirector/PDMR Shareholding
23rd Jul 20137:00 amRNSDirector/PDMR Shareholding
19th Jul 20137:00 amRNSAwards under Long Term Incentive Plan
17th Jul 20131:45 pmRNSAnnual General Meeting 2013
17th Jul 20137:00 amRNSDirectorate Change
17th Jul 20137:00 amRNSInterim Management Statement
1st Jul 20134:35 pmRNSHolding(s) in Company
26th Jun 20134:29 pmRNSHolding(s) in Company
26th Jun 201311:11 amRNSHolding(s) in Company
12th Jun 201312:00 pmRNSDirectorate Change
20th May 20132:20 pmRNSDirector/PDMR Shareholding
20th May 20137:00 amRNSResults for the year ended 31 March 2013
25th Apr 20133:58 pmRNSNotification of Major Interest in Shares
22nd Apr 20135:00 pmRNSNotification of Major Interest in Shares
16th Apr 20137:00 amRNSTrading Statement
9th Apr 201310:00 amRNSTotal Voting Rights
18th Mar 20134:00 pmRNSNotification of Major Interest in Shares
18th Mar 20137:00 amRNSe2v wins ?10m ESA space science contract
6th Mar 20133:11 pmRNSHolding(s) in Company
6th Mar 20132:15 pmRNSHolding(s) in Company
5th Mar 20137:00 amRNSContract Renewal
22nd Feb 20132:02 pmRNSNotification of Major Interest in Shares
14th Feb 201311:00 amRNSDirector/PDMR Shareholding
12th Feb 20134:43 pmRNSDirector/PDMR Shareholding
12th Feb 201311:10 amRNSHolding(s) in Company
11th Feb 20134:13 pmRNSTotal Voting Rights
11th Feb 20137:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20137:00 amRNSInterim Management Statement
8th Jan 201311:40 amRNSTotal Voting Rights
7th Jan 20131:59 pmRNSDirector/PDMR Shareholding
7th Dec 20127:00 amRNSContract Renewal
3rd Dec 20127:00 amRNSSale of land
30th Nov 20123:39 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.